Literature DB >> 23602557

Novel compound heterozygous mutations of the growth hormone-releasing hormone receptor gene in a case of isolated growth hormone deficiency.

Akiko Soneda1, Masanori Adachi, Koji Muroya, Yumi Asakura, Masaki Takagi, Tomonobu Hasegawa, Hiroshi Inoue, Mitsuo Itakura.   

Abstract

OBJECTIVE: To elucidate the pathogenesis of isolated growth hormone (GH) deficiency in a Japanese girl without consanguinity.
DESIGN: A 2-year-old girl of height 77.2 cm (-3.0 SD for Japanese girls) was found to have an insulin-like growth factor (IGF)-1 level of 7 ng/mL and IGF binding protein-3 (IGFBP-3) level of 0.41 μg/mL. GH responded modestly to a series of pharmacological stimulants, increasing to 2.81 ng/mL with insulin-induced hypoglycemia, 3.78 ng/mL with arginine, and 3.93 with GH-releasing hormone (GHRH). Following direct sequencing of the GHRH receptor (GHRHR) gene, evaluation by the luciferase reporter assay, immunofluorescence study, and in vitro splicing assay with minigene constructs was conducted.
RESULTS: Novel compound heterozygous GHRHR gene mutations were identified in the patient. A p.G136V substitution elicited no luciferase activity increment in response to GHRH stimulation, with normal membranous expression. Splicing assay demonstrated that the IVS2+3a>g mutation would lead to aberrant splicing.
CONCLUSIONS: A case of isolated GH deficiency due to novel GHRHR gene mutations was identified.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23602557     DOI: 10.1016/j.ghir.2013.03.003

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  1 in total

1.  Novel growth hormone-releasing hormone receptor gene mutations in Turkish children with isolated growth hormone deficiency.

Authors:  Ahmet Arman; Bumin Nuri Dündar; Ergun Çetinkaya; Nilüfer Erzaim; Atilla Büyükgebiz
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.